Abstract A slightly halophilic myxobacterial strain, SMH-27-4, was isolated from nearshore soil and shown to belong to a new myxobacterium genus based on phylogenetic analysis. This slowly-growing myxobacterium produced the novel antibiotic depsipeptides miuraenamides A and B. Their physico-chemical properties and molecular formulas, C 34 H 42 N 3 O 7 Br and C 34 H 42 N 3 O 7 I, were determined. Miuraenamides A exhibited potent and selective inhibition against a phytopathogenic microorganism, Phytophthora sp., and moderate inhibition against some fungi and yeasts, but was ineffective against bacteria. Both of the metabolites inhibited NADH oxidase at IC 50 values of 50 m M, suggesting, like b -methoxyacrylate-type antibiotics, the electron transfer system of the mitochondrial respiratory chain as the cellular target.
Introduction
Myxobacteria are considered a rich source of unique antibiotics that are rarely produced by other bacteria, actinomycetes and fungi [1ϳ4] . Although myxobacterial strains are rather difficult to isolate and to culture, the potential usefulness of their novel secondary metabolites has been frequently mentioned [4] . Myxobacteria are not only soil bacteria, but inhabit a wide range of natural environments. For example, truely halophilic myxobacteria were isolated from the marine environment in Japan [5] . Moreover, new antifungal compounds, such as haliangicins are produced by a marine myxobacterial strain SMP-2 which belongs to the new genus Haliangium [6ϳ8]. These findings suggested novel myxobacteria as promising sources of new compounds. Therefore, we have continued the effort to isolate unknown myxobacteria from the coastal (Fig. 1) were obtained from the fermentation broth of a new slightly halophilic myxobacterium isolated from a nearshore soil in Miura Peninsula, Japan. We now describe the taxonomy and fermentation characteristics of this myxobacterium as well as the isolation, physicochemical properties and biological activity of these antibiotics.
Materials and Methods

Microorganisms
The myxobacterial strain SMH-27-4 (ϭAJ-110262*) was isolated from a soil sample collected in a brush vegetation near the seashore of Arai-Hama beach in the Miura Peninsula, Kanagawa, Japan. The principal method used for isolation of myxobacteria has been described previously, except that low salt concentration media (one fifth the strength of SWS solution, or 1/5SWS) were used [5] . Phylogenetic and physiological studies were conducted as described [5] .
Fermentation
The myxobacterial strain was cultivated at 27°C in Vy2-1/5SWS medium. The Vy2-1/5SWS medium contained (amount/liter) Baker's yeast cake (5 g, Wako Pure Chemical, Osaka, Japan), NaCl (10 g), cyanocobalamin (0.5 mg), SWS solution [5] (200 ml) and agar (15 g ), at pH 7.2 adjusted with NaOH. SWS is composed of the elements of seawater, such as magnesium, potassium, calcium, sulfate, carbonate, boric acid, strontium, iron, manganese and iodine [5] . The V-1/5SWS-Br medium was used for the production of antibiotics. The medium contained (per liter of 1/5 SWS) Baker's yeast cake (8 g, Wako Pure Chemical), Yeast Extract (0.1 g, Difco Lab., Becton Dickinson & Co., Sparks, MD, USA), NaCl (1.0 g), NaBr (7.0 g), HEPES (2.0 g) and the adsorber resin SP207 (20 g, Mitsubishi Chemical Co., Tokyo, Japan), at pH 7.3 adjusted with NaOH. Fermentation was conducted on a rotary shaker (180 rpm) at 27°C.
Chromatography and Physicochemical Properties
Flash chromatography was conducted using a low-pressure gradient system equipped with an 880-PU HPLC pump and an 880-02 gradient unit (Jasco, Tokyo, Japan). Preparative HPLC was performed on a high-pressure gradient system equipped with PU-1586 and PU-2086 pumps and a UV-1570 detector (Jasco). Specific rotations were determined using a DIP-370 digital polarimeter (Jasco). FT-IR spectra were recorded on a FT-IR-7000S spectrometer (Jasco). UV spectra were recorded on an Ubest-50 UV/VIS spectrophotometer (Jasco). Mass spectra (MS) were recorded on a Mariner Biospectrometry Workstation (Applied Biosystems, Foster City, CA, USA) in the positive ESI mode. A peptide mixture containing angiotensin I, bradykinin and neurotensin was used as an internal standard for high-resolution MS analysis. NMR spectra were recorded on an AMX2 600 (600 MHz) spectrometer (Bruker). The NMR chemical shifts for 1 H and 13 C, respectively, were referenced to the solvent peaks of d H 7.26 (residual CHCl 3 ) and d C 77.0 ppm for CDCl 3 solutions.
Isolation of Miuraenamides A and B
The bacterial cells and the adsorber resin were separated from 14 liters of culture broth by centrifugation followed by two extractions with acetone (1.4 liters) at room temperature for two days. The extracts were combined and concentrated to give an aqueous mixture, which was extracted three times with EtOAc (50 ml). After concentration, the residue (495 mg) was subjected to flash chromatography on silica gel [HI-FLASH SI-40W-M (12 g, 20ϫ60 mm, Yamazen, Osaka), 5ϳ50% (90 minutes), 50ϳ100% (50 minutes) EtOAc in CHCl 3 , 4 ml/minute]. The fractions, eluted with 10ϳ30% EtOAc in CHCl 3 , were combined and concentrated to produce an oil (69 mg), which was subjected to chromatography on silica gel [Wakogel C-300 (7 g, 12ϫ130 mm, Wako Pure Chemical), hexane -EtOAc (1 : 1, 1 : 2, 1 : 3, and 1 : 4)]. The fractions eluted with hexane -EtOAc (1 : 3 and 1 : 4) were combined and evaporated. The residue (17.3 mg) was subjected to reversed-phase HPLC [Develosil ODS UG-5 (10 i.d.ϫ 250 mm, Nomura Chemical, Aichi, Japan), 70% MeOH, 8 ml/minute, detection at 260 nm] to yield miuraenamides A (10.9 mg, Rtϭ31.6 minutes) and B (0.5 mg, Rtϭ35.6 minutes).
Antimicrobial Properties
Anti-Phytophthora (a fungus-like phytopathogen) activity of the extracts of culture broths and chromatographic fractions was assessed according to the method of Ojika et al. [9] . The antimicrobial spectrum was obtained using the serial liquid media dilution method using Yeast Nitrogen Base broth (Difco) with 0.5% glucose for yeast and filamentous fungi, and Mueller-Hinton broth (Difco) for bacteria. Approximately 10 4 freshly grown cells (or spores) of the test strains were inoculated and grown at 25°C for yeast and fungi and at 37°C for bacteria. For the non spore-forming fungal species (Phytophthora capsici and Trichophyton mentagrophytes), small pieces of agar (approximately 1 mm 3 ) containing the mycelia were used as inocula. After incubation for 72 hours for filamentous fungi and 24 hours for yeasts and bacteria, the minimal inhibitory concentrations (MICs) were determined.
NADH Oxidase Inhibition
The inhibition rate of fungal NADH oxidase in Candida rugosa AJ14513 mitochondrial particles was determined using a slight modification of Thierbach et al. [13] . The fungus was cultured with shaking in YM medium at 25°C for 40 hours and used for further experiments. A mitochondrial fraction of the fungal cells was extracted according to the method described by Fang et al. [14] .
Results and Discussion
Taxonomic Studies
The antibiotic depsipeptide producing strain SMH-27-4 (ϭAJ-110262) exhibited enlarging colony formation on agar plates and conspicuous bacteriolytic action; both features are typical characteristics of myxobacteria [4] . However, the strain did not form fruiting bodies whose shapes and structures are important taxonomic features of myxobacteria. Consequently, the strain was subjected to phylogenetic analysis based on 16SrDNA sequences of nearly 1500 bp [DDBJ (ϭDNA Data Bank of Japan, National Institute of Genetics, Mishima, Shizuoka, Japan) Accession No. for the strain: AB252740]. The strain was shown to be related to the suborder Sorangineae myxobacteria, and was positioned near the genus Nannocystis and the marine myxobacterial genera Enhygromyxa and Plesiocystis [15, 16] (Fig. 2) . Homology with its closest relatives was relatively low at 93.0% with Nannocystis exedens, 93.2 to 93.3% with Enhygromyxa salina, and 91.3 to 91.5% with Plesiocystis pacifica. The strain showed the slight salt requirement with an optimum NaCl concentration for growth of approximately 0.5 to 1.0% (w/v), which is slightly lower than that observed for any myxobacteria of marine origin reported to date [5, 15, 16] . Since these results strongly suggested that the strain might represent a novel taxon at the level of genus, we tentatively named it Paraliomyxa miuraensis. A more detailed description of the strain will be reported elsewhere.
Production and Isolation of Antibiotics
After the incubation of the myxobacterial strain on the Vy2-1/5SWS agar plates for 7 to 10 days, agar pieces, taken from the periphery of the colonies with a sterile spatula, were inoculated into 2-liter Erlenmeyer flasks containing 500 ml of the production medium. Cultivation was performed on a rotary shaker at 27°C for 18 days. A total of 14 liters of culture broth was used for further extraction and isolation. The bacterial cells, including the adsorber resin, were extracted with acetone then separated into the EtOAc and water fractions by solvent partition. The EtOAc fraction was chromatographed twice on silica gel before being purified by reversed-phase HPLC to give miuraenamides A (10.9 mg) and B (0.5 mg). Table 1 Fig. 3) , indicating the presence of one bromine atom in the molecules. The molecular formulas were determined by high-resolution ESI-TOF MS. The IR bands of miuraenamide A at 1684 cm Ϫ1 (Fig. 4) and UV absorption at 276 nm (Fig. 5) to those of miuraenamide A except for the molecular formula, in which the bromine atom was replaced by iodine ( Fig. 1) . The 1 H and 13 C NMR spectra of miuraenamide A are shown in Fig. 6 . The details of the chemical attributes of the molecules such as elucidation of the structure will be published elsewhere.
Physicochemical Properties
Biological Activity
Miuraenamides A and B were obtained by antiPhytophthora screening using a paper disk diffusion method. Both compounds inhibited the phytopathogenic oomycete, Phytophthora capsici, at a minimum dose of 25 ng/disk (Fig. 7) . Table 2 shows the antimicrobial spectrum of miuraenamide A. We could not determine the spectrum of miuraenamide B due to the scantiness of the compound available. The spectrum may be very similar to that of miuraenamide A, because of the structural similarity ( Fig. 1) and the same anti-Phytophthora activity. The compound selectively inhibited Phytophthora but did not inhibit bacteria. One of the interesting structural features is the b -methoxyacrylate (and enamide NH-CϭC) moiety of the dehydrophenylalanine residue. Since the bmethoxyacrylate-type metabolites are known to be antifungal respiratory-chain inhibitors, e.g., strobilurins [17] , cystothiazoles [9] and haliangicins [8] , the inhibition of NADH oxidase was evaluated using Candida-derived mitoplast (Fig. 8) and it was found that miuraenamides inhibited NADH oxidase activity at 100 mM. Cystothiazole A, which is a typical b -methoxyacrylate compound previously isolated from a myxobacterium by us [9] , was used as a positive control and completely inhibited NADH oxidase at 10 m M. On the other hand, amphotericin B, which is a potent antifungal compound of the heptaenemacrolide, serving as negative control, did not show inhibition. The IC 50 values of 50 mM were determined in an experiment using various concentrations (data not shown). The results suggest the electron transfer system of the mitochondrial respiratory chain as cellular target, similar to b-methoxyacrylate compounds. The miuraenamides are the second reported example of a -nitrogen-linked bmethoxyacrylates produced by bacteria since the discovery of cyrmenins [18, 19] . 
